121 related articles for article (PubMed ID: 24445696)
1. Clinical and laboratory parameters associated with metabolic syndrome in Turkish patients with psoriasis.
Akcali C; Buyukcelik B; Kirtak N; Inaloz S
J Int Med Res; 2014 Apr; 42(2):386-94. PubMed ID: 24445696
[TBL] [Abstract][Full Text] [Related]
2. Low adiponectin levels in primary hypertriglyceridemic male patients.
Gómez Rosso L; Meroño T; Benítez MB; López G; Giunta G; D'Ambrosio ML; Wikinski R; Cuniberti L; Brites F
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):135-9. PubMed ID: 18472252
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
[TBL] [Abstract][Full Text] [Related]
4. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
Misra KB; Endemann SW; Ayer M
Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
[TBL] [Abstract][Full Text] [Related]
5. Metabolic risk factors associated with erosive esophagitis.
Chua CS; Lin YM; Yu FC; Hsu YH; Chen JH; Yang KC; Shih CH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1375-9. PubMed ID: 19467140
[TBL] [Abstract][Full Text] [Related]
6. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome.
Salas-Salvadó J; Granada M; Bulló M; Corominas A; Casas P; Foz M
Metabolism; 2007 Nov; 56(11):1486-92. PubMed ID: 17950098
[TBL] [Abstract][Full Text] [Related]
7. Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis.
Romaní J; Caixàs A; Carrascosa JM; Ribera M; Rigla M; Luelmo J
Br J Dermatol; 2012 Jun; 166(6):1237-44. PubMed ID: 22309899
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study.
Kothiwala SK; Khanna N; Tandon N; Naik N; Sharma VK; Sharma S; Sreenivas V
Indian J Dermatol Venereol Leprol; 2016; 82(5):510-8. PubMed ID: 27297282
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of metabolic syndrome in patients with psoriasis.
Nisa N; Qazi MA
Indian J Dermatol Venereol Leprol; 2010; 76(6):662-5. PubMed ID: 21079309
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular comorbidities in childhood psoriasis.
Torres T; Machado S; Mendonça D; Selores M
Eur J Dermatol; 2014; 24(2):229-35. PubMed ID: 24752043
[TBL] [Abstract][Full Text] [Related]
12. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP
Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of metabolic syndrome in patients with psoriasis at Mostar Clinical Hospital.
Topić I; Simić D
Acta Clin Croat; 2013 Mar; 52(1):53-8. PubMed ID: 23837273
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
15. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
16. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults.
Can AS; Ozbayrakçi S; Palaoğlu KE; Bersot TP
J Cardiometab Syndr; 2009; 4(1):26-32. PubMed ID: 19245513
[TBL] [Abstract][Full Text] [Related]
17. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.
Chen YJ; Wu CY; Shen JL; Chu SY; Chen CK; Chang YT; Chen CM
Arch Dermatol; 2008 Dec; 144(12):1571-5. PubMed ID: 19075139
[TBL] [Abstract][Full Text] [Related]
18. Do the prevalence and components of metabolic syndrome differ among different ethnic groups? A cross-sectional study among obese Malaysian adolescents.
Narayanan P; Meng OL; Mahanim O
Metab Syndr Relat Disord; 2011 Oct; 9(5):389-95. PubMed ID: 21718129
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome as per the NCEP and IDF definitions vis-a-vis severity and duration of psoriasis in a semi-urban Maharashtrian population: A case control study.
Sharma YK; Prakash N; Gupta A
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S72-6. PubMed ID: 26832843
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factors in patients with chronic plaque psoriasis: a case-control study on the Brasov County population.
Irimie M; Oanţă A; Irimie CA; Fekete LG; Minea DI; Pascu A
Acta Dermatovenerol Croat; 2015; 23(1):28-35. PubMed ID: 25969910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
